ArticleNature communications2019
A high-throughput screen indicates gemcitabine and JAK inhibitors may be useful for treating pediatric AML.
Christina D Drenberg et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
27 papers cite it
this papercites it